Sabrina Vari

First-Line Osimertinib in Patients with <i>EGFR</i>-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

M. Lorenzi, Alessandra Ferro, Fabiana Letizia Cecere et al. · The Oncologist · 2021 · 62 citations · Full text

Medicine, Oncology, Pharmacology +15

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study

Maria Rita Migliorino, Antonio Santo, Giampiero Romano et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 58 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors

Alessio Annovazzi, Sabrina Vari, Diana Giannarelli et al. · Clinical Nuclear Medicine · 2019 · 35 citations

Medicine, Nuclear Medicine, Oncology +17

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients

Alessandra Fabi, Diana Giannarelli, Paola Malaguti et al. · Drug Design Development and Therapy · 2015 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

Nodal Upstaging Evaluation After Robotic-Assisted Lobectomy for Early-Stage Non-small Cell Lung Cancer Compared to Video-Assisted Thoracic Surgery and Thoracotomy: A Retrospective Single Center Analysis

Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella et al. · Frontiers in Surgery · 2021 · 28 citations · Full text

Medicine, Oncology, Surgery +16